| Code No. | W158-3 | |
| Anti-HEXA (Human) mAb | ||
| Size | 100 µL (1 mg/mL) | |
| Availability (in Japan) | 10 or more
(In Japan at 17:01, Feb 16, 2026 in JST) |
|
| Clonality | Monoclonal | |
| Clone | 2D7C1C | |
| Isotype (Immunized Animal) |
Mouse IgG2aκ | |
| Applications | FCM 10 µg/mL |
|
| Immunogen (Antigen) |
Human HEXA expressed Ba/F3 transfectants generated from SST-REX (signal sequence trap by retrovirus-mediated expression screening). | |
| Reactivity [Gene ID] | Human[3073] |
|
| Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
| Storage temp. | -20°C | |
| Conjugate | Unlabeled | |
| Manufacturer | MBL | |
| Alternative names | TSD | |
| Background | Beta-hexosaminidase subunit alpha (HEXA) is the alpha subunit of the lysosomal enzyme beta-hexosaminidase. It catalyzes the degradation of the ganglioside GM2 and other molecules containing terminal N-acetyl hexosamines. Mutation of HEXA leads to GM2-gangliosidosis Type I | |
| Related products | M076-3 Mouse IgG2a (isotype control) MTG-001 Clear Back (Human Fc receptor blocking reagent) W164-3 Anti-RHBDD3 (Human) mAb |
|
| Product category | Research area:Cancer Neuroscience | |
| Data | ![]() |
|
| References |
|
|
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve